A Viral Hepatitis Pre-Conference was convened as part of the Harm Reduction International 2023 Conference in Melbourne, Australia, situated in the Western Pacific Region which has the highest prevalence of hepatitis B in the world.  

People who use drugs have the right to be protected from hepatitis B infection, to know their hepatitis B status, and to have equitable and affordable access to prevention, treatment and care.  

People who use drugs are significantly and disproportionately affected by the health and social impacts of hepatitis B, however to-date hepatitis B has been neglected in harm reduction programs and policies.  

Download the statement